Hepatology
Conference Coverage
HBV: Rethink the free pass for immune tolerant patients
MAUI, HAWAII – Not treating means more liver cancer.
Conference Coverage
NASH ‘an epidemic of the 21st century’
LOS ANGELES – Recent guidelines recognize the association between diabetes, NAFLD, and NASH, and call for more vigilance and screening tests.
Conference Coverage
Novel approaches to treating NASH in diabetes
BARCELONA –
Conference Coverage
What’s new in hepatitis C: Four themes that dominated at the Liver Meeting
BOSTON – AASLD highlights included treatment of persons who inject drugs, new directions in pangenotypic therapy,...
Latest News
AASLD debrief: Five drugs show promise in NAFLD (and two do not)
BOSTON – Promising new data for cotadutide, licogliflozin, tropifexor, saroglitazar, and PF-05221304 highlighted in...
Conference Coverage
TARGET-NASH: One-third of NAFLD, NASH patients lost weight, but not all kept it off
BOSTON – With no approved pharmacologic treatments for NAFLD and NASH, weight reduction remains one of the mainstays of treatment.
Conference Coverage
ED-based HCV screening found feasible, linkage low
BOSTON – Among patients with homes, linkage to care was 59%, compared with 20% for patients who were homeless.
Conference Coverage
Hepatitis B debrief: Key themes that emerged at AASLD
BOSTON – Hot topics included HBV natural history, novel therapies, and prevention.
Conference Coverage
Kratom: Botanical with opiate-like effects increasingly blamed for liver injury
BOSTON – Kratom-associated liver damage involves a mixed pattern of hepatocellular and cholestatic injury.
From the Journals
Hepatitis C vaccine alters viral trajectory, but fails in chronic infection protection
BOSTON – First-ever randomized study does suggest changes in peak HCV RNA and an HCV RNA change after infection.
Photo Rounds
Chronic blistering rash on hands
The location of the patient’s lesions and multiple risk factors suggested that an uncommon disorder was at work.